If patients do not tolerate a dose during dose escalation, consider delaying dose escalation for 4 weeks The maintenance dosages of Wegovy for weight reduction in adults are 1.7 mg, 2.4 mg (recommended), or 7.2 mg (when additional weight reduction is clinically indicated) injected subcutaneously once weekly
Whether your goal is accelerated fat reduction, appetite control, improved energy, or long-term body recomposition, Retatrutide delivers science-driven results backed by clinical research
Avoid use if you have a personal or family history of MTC or MEN 2
If you experience dizziness, lightheadedness, or unusual fatigue after starting semaglutide while on blood pressure medication, contact your healthcare provider immediately
Research shows up to 40% of weight lost on GLP-1 medications is lean muscle, not fat
Targeting enteric release of therapeutic peptides by encapsulation in complex coacervated matrix microparticles by spray drying